Physician profile
John Scott Baker
NPI 1407989353
$310.29
in general payments reported to CMS, 2019-2025
9 companies · $88.63 in 2025
The $88.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.51 · 2022: $42.85 · 2023: $94.54 · 2024: $56.76 · 2025: $88.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.69 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $85.15 | 2021-2025 | Evenity, Prolia, Repatha |
| Insmed, INC. | $62.30 | 2024-2025 | Arikayce |
| Janssen Pharmaceuticals, INC | $44.19 | 2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $26.43 | 2023 | Rexulti |
| Exact Sciences Corporation | $25.27 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $23.92 | 2023 | Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $15.43 | 2022 | |
| Abbvie INC. | $14.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.